Fortis defers approval of Q4 results, board meeting to reconvene today

Stock Market - Newly-appointed board of Fortis Healthcare, which is in the process of finding an investor, has again deferred approval of quarterly and annual financial results for the period ended March 31, 2018, saying the issue requires more deliberation.

The board, which met on June 25 for considering results, will reconvene on Tuesday.

"This is to inform that the Board of Directors of the company held a meeting on June 25, 2018, for considering the standalone and consolidated annual accounts for 2017-18 along with the financial results for the quarter and period ended March 31, 2018.

"The members of the board deliberated upon the same and had a detailed discussion with the management, legal advisors and the statutory auditors," Fortis said in a regulatory filing.

It further said in view of the ongoing discussions on the annual accounts, which requires further deliberation, the board decided to adjourn the meeting to be reconvened today.

Get Live Fortis Healthcare Stock Price